Terms: = Ovarian cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Treatment
8 results:
1. A Comprehensive Analysis of Prognostic Indicators in Serous ovarian cancer Based on Leukocyte Migration and Immune Microenvironment.
Pan J; Chen X; Yang L; Song Y; Liu J; Li L; Lin Y; Tang L; Qiu S; Xu Q
Front Biosci (Landmark Ed); 2023 Jun; 28(6):130. PubMed ID: 37395023
[TBL] [Abstract] [Full Text] [Related]
2. Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting myb.
Li P; Xin H; Lu L
J Transl Med; 2021 Jan; 19(1):4. PubMed ID: 33407591
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.
Peng X; Yu M; Chen J
J Int Med Res; 2020 Sep; 48(9):300060520950912. PubMed ID: 32878513
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA-150-5p promotes cell motility by inhibiting c-myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
[TBL] [Abstract] [Full Text] [Related]
5. The activation of microRNA-520h-associated TGF-β1/c-myb/Smad7 axis promotes epithelial ovarian cancer progression.
Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
[TBL] [Abstract] [Full Text] [Related]
6. A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in cancer Cell Dormancy.
MacDonald J; Ramos-Valdes Y; Perampalam P; Litovchick L; DiMattia GE; Dick FA
Mol Cancer Res; 2017 Apr; 15(4):371-381. PubMed ID: 28031411
[TBL] [Abstract] [Full Text] [Related]
7. [Novel role of growth factors in ovary function].
Amsterdam A
Harefuah; 2010 Dec; 149(12):789-93, 811, 810. PubMed ID: 21916103
[TBL] [Abstract] [Full Text] [Related]
8. [Primary fallopian tube carcinoma].
Mladenović-Segedi L
Med Pregl; 2009; 62(1-2):31-6. PubMed ID: 19514598
[TBL] [Abstract] [Full Text] [Related]
